Materias dentro de su búsqueda.
Mostrando 2,461 - 2,480 Resultados de 15,611 Para Buscar '"pancreatic cancer"', tiempo de consulta: 2.12s Limitar resultados
  1. 2461
    “…AIM: To analyze the diagnostic value of a circular RNA (circRNA), circ-LDLRAD3, in pancreatic cancer. METHODS: Expression levels of circ-LDLRAD3 were tested in both cells and clinical samples; the latter included 30 paired pancreatic cancer tissues and adjacent non-tumorous tissues, 31 plasma samples from patients with pancreatic cancer, and 31 plasma samples from healthy volunteers. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Circular RNA circ-LDLRAD3 as a biomarker in diagnosis of pancreatic cancer
  2. 2462
    “…Pancreatic cancer is one of the most lethal cancers worldwide due to its insidious symptoms, early metastasis, and chemoresistance. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications
  3. 2463
    por Bravo, Jerónimo, Neira, José L.
    Publicado 2010
    “…Pancreatic cancer (PC) is one of the most difficult illnesses to treat, since the 5-year survival rate is lower than 5% in patients and no substantial advances in its treatment have been achieved in the last 20 years. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Folded and Unfolded Conformations of Proteins Involved in Pancreatic Cancer: a Layman's Guide
  4. 2464
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Correction: Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel
  5. 2465
    por van Duijnhoven, Fränzel J.B., Jenab, Mazda, Hveem, Kristian, Siersema, Peter D., Fedirko, Veronika, Duell, Eric J., Kampman, Ellen, Halfweeg, Anouk, van Kranen, Henk J., van den Ouweland, Jody M.W., Weiderpass, Elisabete, Murphy, Neil, Langhammer, Arnulf, Ness‐Jensen, Eivind, Olsen, Anja, Tjønneland, Anne, Overvad, Kim, Cadeau, Claire, Kvaskoff, Marina, Boutron‐Ruault, Marie‐Christine, Katzke, Verena A., Kühn, Tilman, Boeing, Heiner, Trichopoulou, Antonia, Kotanidou, Anastasia, Kritikou, Maria, Palli, Domenico, Agnoli, Claudia, Tumino, Rosario, Panico, Salvatore, Matullo, Giuseppe, Peeters, Petra, Brustad, Magritt, Olsen, Karina Standahl, Lasheras, Cristina, Obón‐Santacana, Mireia, Sánchez, María‐José, Dorronsoro, Miren, Chirlaque, Maria‐Dolores, Barricarte, Aurelio, Manjer, Jonas, Almquist, Martin, Renström, Frida, Ye, Weimin, Wareham, Nick, Khaw, Kay‐Tee, Bradbury, Kathryn E., Freisling, Heinz, Aune, Dagfinn, Norat, Teresa, Riboli, Elio, Bueno‐de‐Mesquita, H. B(as)
    Publicado 2017
    “…Evidence from in vivo, in vitro and ecological studies are suggestive of a protective effect of vitamin D against pancreatic cancer (PC). However, this has not been confirmed by analytical epidemiological studies. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Circulating concentrations of vitamin D in relation to pancreatic cancer risk in European populations
  6. 2466
    “…In conclusion, SEMA5A signaling represents a potential molecule for targeting metastasis in pancreatic cancer.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasis
  7. 2467
    por Yin, Hang, Wang, Lei, Liu, Hai-Lin
    Publicado 2018
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    ENO1 Overexpression in Pancreatic Cancer Patients and Its Clinical and Diagnostic Significance
  8. 2468
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Piperlongumine potentiates the effects of gemcitabine in in vitro and in vivo human pancreatic cancer models
  9. 2469
    “…However, the expression and function of PKM2 in pancreatic cancer (PC) remain undefined. Our results showed that PKM2 is overexpressed in the PC tissue compared to the peritumoral tissue. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The responsively decreased PKM2 facilitates the survival of pancreatic cancer cells in hypoglucose
  10. 2470
    “…The most common symptom in patients with advanced pancreatic cancer is abdominal pain. This has traditionally been treated with nonsteroidal anti-inflammatory drugs and opioid analgesics. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Alleviating Pancreatic Cancer-Associated Pain Using Endoscopic Ultrasound-Guided Neurolysis
  11. 2471
    “…CONCLUSIONS: FLT PET allows risk stratification for death in patients with resectable pancreatic cancer prior to surgery.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    (18)F-fluorothymidine PET for predicting survival in patients with resectable pancreatic cancer
  12. 2472
    “…While gemcitabine has been the mainstay therapy for advanced pancreatic cancer, newer combination regimens (e.g. FOLFIRINOX) have extended patient survival, though carry greater toxicity. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    SWI/SNF aberrations sensitize pancreatic cancer cells to DNA crosslinking agents
  13. 2473
    “…Pancreatic cancer is an aggressive disease with a particularly poor prognosis contributing to a substantial percentage of cancer-associated mortality rates. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Inhibitory effect of baicalein combined with gemcitabine in human pancreatic cancer cell lines
  14. 2474
    “…To date, limited therapeutic options are available, and research in the field is hampered by the lack of satisfactory models to study the complexity of wasting in cachexia-inducing tumors, such as pancreatic cancer. Moreover, currently used in vivo models are characterized by an explosive cachexia with a lethal wasting within few days, while pancreatic cancer patients might experience alterations long before the onset of overt wasting. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Metabolic Alterations in a Slow-Paced Model of Pancreatic Cancer-Induced Wasting
  15. 2475
    “…Pancreatic cancer is one of the deadliest cancers with very poor prognosis, and the five-year survival rate of the patients is less than 5% after diagnosis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Kallikrein-related peptidase 7 is a potential target for the treatment of pancreatic cancer
  16. 2476
    por Doiron, Bruno, DeFronzo, Ralph A
    Publicado 2018
    “…Pancreatic cancer has remained refractory to treatment. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A novel experimental model for human mixed acinar–ductal pancreatic cancer
  17. 2477
    por Kenner, Barbara J.
    Publicado 2018
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Early Detection of Pancreatic Cancer: The Role of Depression and Anxiety as a Precursor for Disease
  18. 2478
    “…However, its role in pancreatic cancer and the underlying molecular mechanisms are poorly defined. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Natural Compound Methyl Protodioscin Suppresses Proliferation and Inhibits Glycolysis in Pancreatic Cancer
  19. 2479
    “…This combination regimen would be a novel strategy for treating pancreatic cancer.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pomalidomide enhanced gemcitabine and nab-paclitaxel on pancreatic cancer both in vitro and in vivo
  20. 2480
    “…This report summarizes results from an initial clinical evaluation of radioimnumodetection (RAID) in patients with pancreatic cancer using murine monoclonal antibody Nd2, directed against mucins from pancreatic cancer.Nd2 (2 mg) was labeled with (111)ln (2 mCi) and injected into 19 patients suspected of having pancreatic cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Radioimmunodetection with (111)In–labeled Monoclonal Antibody Nd2 in Patients with Pancreatic Cancer
Herramientas de búsqueda: RSS